Drugs / INSULIN HUMAN ZINC
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | Monotard | — | 2006-11-14 | europa.eu ↗ |
| Approved | EU (EMA) | Monotard | — | 2002-10-07 | europa.eu ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials · 1 missed | ||||||
| — | NCT01957930 | Jan 1984 → Dec 2011 | ulcer of lower limbs | Karolinska Institutet | Completed | No outcome recorded |
| — | NCT02138006 | Sep 1982 → Dec 2011 | coronary artery disorder, kidney failure, stroke disorder | Karolinska Institutet | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT00506194 Background | Oct 2005 → Aug 2007 | type 2 diabetes mellitus | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INSULIN HUMAN ZINC | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108974 ↗ |
| Known as | Monotard | “Basal (Monotard) insulin; ones a day Bolus (Actrapid) insulin; thrice a day” NCT01957930 ↗ |
| Known as | Ultratard | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108974 ↗ |
| Action | Activate | “Insulin receptor agonist” CHEMBL2108974 ↗ |
| Modality | Protein / enzyme biologic | “Basal (Monotard) insulin” NCT01957930 ↗ |
| Target | INSR | “Insulin receptor agonist” CHEMBL2108974 ↗ |